Tobias Larsson

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ATHEROSCLEROSIS. 2015;242(2):483-489
Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
Brandenburg VM; Kleber ME; Vervloet MG; Larsson TE; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; Maerz W; Scharnagl H
Article: CARDIORENAL MEDICINE. 2015;5(4):278-288
Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals
Carlsson AC; Nordquist L; Larsson TE; Carrero J-J; Larsson A; Lind L; Arnlov J
Article: CLINICAL NEPHROLOGY. 2015;83(6):315-321
In the backwater of convective dialysis: decreased 25-hydroxyvitamin D levels following the switch to online hemodiafiltration
Uhlin F; Magnusson P; Larsson TE; Fernstrom A
Article: NATURE BIOTECHNOLOGY. 2015;33(5):503-509
High-throughput spatial mapping of single-cell RNA-seq data to tissue of origin.
Achim K; Pettit J-B; Saraiva LR; Gavriouchkina D; Larsson T; Arendt D; Marioni JC
Article: OSTEOPOROSIS INTERNATIONAL. 2015;26(2):563-570
Dietary acid load, kidney function, osteoporosis, and risk of fractures in elderly men and women
Jia T; Byberg L; Lindholm B; Larsson TE; Lind L; Michaelsson K; Carrero JJ
Article: ATHEROSCLEROSIS. 2014;237(1):236-242
Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes - Findings from two community based cohorts of elderly
Carlsson AC; Juhlin CC; Larsson TE; Larsson A; Ingelsson E; Sundstrom J; Lind L; Arnlov J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29(10):1815-1820
Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Cozzolino M; Urena-Torres P; Vervloet MG; Brandenburg V; Bover J; Goldsmith D; Larsson TE; Massy ZA; Mazzaferro S
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2014;25(10):2169-2175
The Kidney Is the Principal Organ Mediating Klotho Effects
Lindberg K; Amin R; Moe OW; Hu M-C; Erben RG; Wernerson AO; Lanske B; Olauson H; Larsson TE
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2014;9(8):1393-1401
Urinary Kidney Injury Molecule-1 and the Risk of Cardiovascular Mortality in Elderly Men
Carlsson AC; Larsson A; Helmersson-Karlqvist J; Lind L; Ingelsson E; Larsson TE; Bottai M; Sundstrom J; Arnlov J
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2014;25(6):1313-1320
Soluble TNF Receptors and Kidney Dysfunction in the Elderly
Carlsson AC; Larsson TE; Helmersson-Karlqvist J; Larsson A; Lind L; Arnlov J
Article: CURRENT VASCULAR PHARMACOLOGY. 2014;12(2):339-349
Vitamin D Metabolites and/or Analogs: Which D for Which Patient?
Mazzaferro S; Goldsmith D; Larsson TE; Massy ZA; Cozzolino M
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2014;40(5):417-424
Endostatin Level is Associated with Kidney Injury in the Elderly: Findings from Two Community-Based Cohorts
Ruge T; Carlsson AC; Larsson TE; Carrero J-J; Larsson A; Lind L; Arnlov J
Article: CALCIFIED TISSUE INTERNATIONAL. 2013;93(6):556-564
FGF23 Affects the Lineage Fate Determination of Mesenchymal Stem Cells
Li Y; He X; Olauson H; Larsson TE; Lindgren U
Article: BMC NEPHROLOGY. 2013;14:116
A novel model of adenine-induced tubulointerstitial nephropathy in mice
Jia T; Olauson H; Lindberg K; Amin R; Edvardsson K; Lindholm B; Andersson G; Wernerson A; Sabbagh Y; Schiavi S; Larsson TE
Article: JOURNAL OF NEPHROLOGY. 2013;26(3):485-494
Determinants and survival implications of low bone mineral density in end-stage renal disease patients
Park S-H; Jia T; Qureshi AR; Barany P; Heimburger O; Larsson TE; Axelsson J; Stenvinkel P; Lindholm B
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2013;8(5):781-786
Serum FGF23 and Risk of Cardiovascular Events in Relation to Mineral Metabolism and Cardiovascular Pathology
Arnlov J; Carlsson AC; Sundstrom J; Ingelsson E; Larsson A; Lind L; Larsson TE
Article: BMC NEPHROLOGY. 2013;14:85
Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)
Westerberg P-A; Tivesten A; Karlsson MK; Mellstrom D; Orwoll E; Ohlsson C; Larsson TE; Linde T; Ljunggren O
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2013;15(4):441-446
Urinary kidney injury molecule 1 and incidence of heart failure in elderly men
Carlsson AC; Larsson A; Helmersson-Karlqvist J; Lind L; Ingelsson E; Larsson TE; Sundstrom J; Arnlov J
Article: KIDNEY INTERNATIONAL. 2013;83(1):160-166
Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
Arnlov J; Carlsson AC; Sundstrom J; Ingelsson E; Larsson A; Lind L; Larsson TE
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2013;37(5):462-471
Determinants of Fibroblast Growth Factor-23 and Parathyroid Hormone Variability in Dialysis Patients
Jia T; Qureshi AR; Brandenburg V; Ketteler M; Barany P; Heimburger O; Uhlin F; Magnusson P; Fernstrom A; Lindholm B; Stenvinkel P; Larsson TE
Article: PLOS ONE. 2013;8(4):e60658
Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function
Lindberg K; Olauson H; Amin R; Ponnusamy A; Goetz R; Taylor RF; Mohammadi M; Canfield A; Kublickiene K; Larsson TE
Article: PLOS GENETICS. 2013;9(12):e1003975
Parathyroid-Specific Deletion of Klotho Unravels a Novel Calcineurin-Dependent FGF23 Signaling Pathway That Regulates PTH Secretion
Olauson H; Lindberg K; Amin R; Sato T; Jia T; Goetz R; Mohammadi M; Andersson G; Lanske B; Larsson TE
Article: PLOS ONE. 2013;8(9):e72934
Metabolic Changes in Summer Active and Anuric Hibernating Free-Ranging Brown Bears (Ursus arctos)
Stenvinkel P; Frobert O; Anderstam B; Palm F; Eriksson M; Bragfors-Helin A-C; Qureshi AR; Larsson T; Friebe A; Zedrosser A; Josefsson J; Svensson M; Sahdo B; Bankir L; Johnson RJ
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012;23(10):1641-1651
Targeted Deletion of Klotho in Kidney Distal Tubule Disrupts Mineral Metabolism
Olauson H; Lindberg K; Amin R; Jia T; Wernerson A; Andersson G; Larsson TE
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012;7(5):727-734
FGF23, Albuminuria, and Disease Progression in Patients with Chronic IgA Nephropathy
Lundberg S; Qureshi AR; Olivecrona S; Gunnarsson I; Jacobson SH; Larsson TE
Article: ENDOCRINOLOGY. 2012;153(4):1795-1805
Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor.
Streicher C; Zeitz U; Andrukhova O; Rupprecht A; Pohl E; Larsson TE; Windisch W; Lanske B; Erben RG
Article: JOURNAL OF BONE AND MINERAL RESEARCH. 2011;26(4):857-864
Serum Fibroblast Growth Factor-23 (FGF-23) and Fracture Risk in Elderly Men
Mirza MA; Karlsson MK; Mellstrom D; Orwoll E; Ohlsson C; Ljunggren O; Larsson TE
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2011;31(1):219-227
Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals
Mirza MAI; Alsio J; Hammarstedt A; Erben RG; Michaelsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellstrom D; Lind L; Ohlsson C; Larsson TE
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(12):4068-4071
Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy
Westerberg P-A; Ljunggren O; Larsson TE; Wadstrom J; Linde T
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2010;12(11):1186-1192
Plasma parathyroid hormone and risk of congestive heart failure in the community
Hagstrom E; Ingelsson E; Sundstrom J; Hellman P; Larsson TE; Berglund L; Melhus H; Held C; Michaelsson K; Lind L; Arnlov J
Article: KIDNEY INTERNATIONAL. 2010;78(10):1024-1032
Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients
Krajisnik T; Olauson H; Mirza MAI; Hellman P; Akerstrom G; Westin G; Larsson TE; Bjorklund P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(9):3033-3038
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
Olauson H; Qureshi AR; Miyamoto T; Barany P; Heimburger O; Lindholm B; Stenvinkel P; Larsson TE
Article: ENDOCRINE. 2010;37(2):244-248
Mutation analysis and serum FGF23 level in a patient with pulmonary alveolar microlithiasis
Olauson H; Brandenburg V; Larsson TE
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2010;30(2):333-339
Conjoint Effects of Serum Calcium and Phosphate on Risk of Total, Cardiovascular, and Noncardiovascular Mortality in the Community
Larsson TE; Olauson H; Hagstrom E; Ingelsson E; Arnlov J; Lind L; Sundstrom J
Article: ATHEROSCLEROSIS. 2009;207(2):546-551
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Mirza MAI; Larsson A; Melhus H; Lind L; Larsson TE
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009;24(10):3125-3131
Relationship between circulating FGF23 and total body atherosclerosis in the community
Mirza MAI; Hansen T; Johansson L; Ahlstrom H; Larsson A; Lind L; Larsson TE
Article: ATHEROSCLEROSIS. 2009;205(2):385-390
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Mirza MAI; Larsson A; Lind L; Larsson TE
Article: OSTEOPOROSIS INTERNATIONAL. 2009;20(7):1167-1173
Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men.
Marsell R; Mirza MAI; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
Article: CIRCULATION. 2009;119(21):2765-2771
Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
Hagstrom E; Hellman P; Larsson TE; Ingelsson E; Berglund L; Sundstrom J; Melhus H; Held C; Lind L; Michaelsson K; Arnlov J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2008;93(10):4152-4157
Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
Björklund P; Krajisnik T; Akerström G; Westin G; Larsson TE
Article: BONE. 2008;42(6):1111-1121
Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice
Hollberg K; Marsell R; Norgard M; Larsson T; Jonsson KB; Andersson G
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2008;158(6):929-934
A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome.
Olauson H; Krajisnik T; Larsson C; Lindberg B; Larsson TE
Article: ENDOCRINE PRACTICE. 2008;14(3):362-367
Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia.
Westerberg P-A; Olauson H; Toss G; Wikström B; Morales O; Linde T; Jonsson K; Ljunggren O; Larsson TE
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2008;23(3):827-833
Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.
Marsell R; Krajisnik T; Göransson H; Ohlsson C; Ljunggren O; Larsson TE; Jonsson KB
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2008;158(1):125-129
Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(11):3202-3207
Regulation of fibroblast growth factor-23 in chronic kidney disease.
Westerberg P-A; Linde T; Wikström B; Ljunggren O; Stridsberg M; Larsson TE
Article: JOURNAL OF ENDOCRINOLOGY. 2007;195(1):125-131
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
Krajisnik T; Björklund P; Marsell R; Ljunggren O; Akerström G; Jonsson KB; Westin G; Larsson TE
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2006;91(10):4037-4042
The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
Garringer HJ; Fisher C; Larsson TE; Davis SI; Koller DL; Cullen MJ; Draman MS; Conlon N; Jain A; Fedarko NS; Dasgupta B; White KE
Article: ENDOCRINOLOGY. 2005;146(9):3883-3891
Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed.
Larsson T; Davis SI; Garringer HJ; Mooney SD; Draman MS; Cullen MJ; White KE
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2005;90(4):2424-2427
A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.
Larsson T; Yu X; Davis SI; Draman MS; Mooney SD; Cullen MJ; White KE
Article: ENDOCRINOLOGY. 2004;145(7):3087-3094
Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.
Larsson T; Marsell R; Schipani E; Ohlsson C; Ljunggren O; Tenenhouse HS; Jüppner H; Jonsson KB
Article: KIDNEY INTERNATIONAL. 2003;64(6):2272-2279
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
Larsson T; Nisbeth U; Ljunggren O; Jüppner H; Jonsson KB
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2003;348(17):1656-1663
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2003;148(2):269-276
Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia.
Larsson T; Zahradnik R; Lavigne J; Ljunggren O; Jüppner H; Jonsson KB
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2001;145(4):469-476
Diagnosis of a patient with oncogenic osteomalacia using a phosphate uptake bioassay of serum and magnetic resonance imaging.
Nelson AE; Mason RS; Robinson BG; Hogan JJ; Martin EA; Ahlström H; Aström G; Larsson T; Jonsson K; Wibell L; Ljunggren O
Visa fler

Alla övriga publikationer

Review: SEMINARS IN NEPHROLOGY. 2014;34(6):648-659
Calcium-Sensing Receptor Activation in Chronic Kidney Disease: Effects Beyond Parathyroid Hormone Control
Massy ZA; Henaut L; Larsson TE; Vervloet MG
Review: SEMINARS IN NEPHROLOGY. 2014;34(6):586-597
New Insights Into the FGF23-Klotho Axis
Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Torres PU; Larsson TE
Review: SEMINARS IN NEPHROLOGY. 2014;34(6):578-585
The Role of Klotho on Vascular Calcification and Endothelial Function in Chronic Kidney Disease
Vervloet MG; Adema AY; Larsson TE; Massy ZA
Review: GIORNALE ITALIANO DI NEFROLOGIA. 2014;31(2):gin/31.2.11
[A brief update on FGF23 for the clinical nephrologist].
Larsson T; Olauson H
Letter: KIDNEY INTERNATIONAL. 2013;84(3):621
Metabolic acidosis may increase fibroblast growth factor-23 and cardiovascular mortality in the community Reply
Arnlov J; Larsson TE
Review: AMERICAN JOURNAL OF KIDNEY DISEASES. 2013;62(2):339-351
Chronic Kidney Disease: A Clinical Model of Premature Aging
Stenvinkel P; Larsson TE
Review: CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 2013;22(4):397-404
FGF23 and Klotho in chronic kidney disease
Olauson H; Larsson TE
Review: CELL METABOLISM. 2012;16(6):693-705
Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal
Angelin B; Larsson TE; Rudling M
Editorial comment: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2011;6(12):2735-2737
FGF23 Beyond Mineral Metabolism: A Bridge to Cardiovascular Disease
Larsson TE
Review: KIDNEY INTERNATIONAL SUPPLEMENTS. 2011;1(4):130-135
Fibroblast growth factor-23 and Klotho in chronic kidney disease
Vervloet MG; Larsson TE
Review: LAKARTIDNINGEN. 2010;107(46):2884-2887
[Vitamin D deficiency in kidney failure. Risk factor for cardiovascular disease].
Ohman K; Larsson T; Spaak J
Review: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(5):1376-1381
The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?
Larsson TE
Review: ENDOCRINE REVIEWS. 2006;27(3):221-241
The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23.
White KE; Larsson TE; Econs MJ

Anställningar

Anknuten till Forskning, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2024-2026

Examina och utbildning

Docent, experimentell medicin, Karolinska Institutet, 2011

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI